Stay updated on Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4; no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a Locations section with Texas and updated to revision v3.3.3. Removed the old Texas Locations label and the HHS Vulnerability Disclosure link (from v3.3.2).SummaryDifference0.2%

- Check55 days agoChange DetectedA new revision label Revision: v3.3.2 was added and Revision: v3.2.0 was removed, indicating a minor version update to the page.SummaryDifference0.0%

- Check62 days agoChange DetectedThe top government funding status notice has been removed.SummaryDifference0.3%

- Check77 days agoChange DetectedResults section added to the Study Record, including the Results First Submitted and Results First Posted dates. This update provides posted results data and clarifies when results were made available.SummaryDifference0.3%

- Check105 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference2%

Stay in the know with updates to Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page.